Anne Gershon

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Disorders

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Michalik David E; Steinberg Sharon P; Larussa Philip S; Edwards Kathryn M; Wright Peter F; Arvin Ann M; Gans Haley A; Gershon Anne A
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
Gershon Anne A; Chen Jason; Gershon Michael D
A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons.
Gershon Anne A; Arvin Ann M; Levin Myron J; Seward Jane F; Schmid D Scott
Varicella vaccine in the United States: a decade of prevention and the way forward.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Anne Gershon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Michalik David E; Steinberg Sharon P; Larussa Philip S; Edwards Kathryn M; Wright Peter F; Arvin Ann M; Gans Haley A; Gershon Anne A
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
The Journal of infectious diseases 2008;197(7):944-9.
2008: Gershon Anne A; Chen Jason; Gershon Michael D
A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons.
The Journal of infectious diseases 2008;197 Suppl 2():S61-5.
2008: Gershon Anne A; Arvin Ann M; Levin Myron J; Seward Jane F; Schmid D Scott
Varicella vaccine in the United States: a decade of prevention and the way forward.
The Journal of infectious diseases 2008;197 Suppl 2():S39-40.
2008: Gershon Anne A; Katz Samuel L
Perspective on live varicella vaccine.
The Journal of infectious diseases 2008;197 Suppl 2():S242-5.
2008: Hambleton Sophie; Steinberg Sharon P; Larussa Philip S; Shapiro Eugene D; Gershon Anne A
Risk of herpes zoster in adults immunized with varicella vaccine.
The Journal of infectious diseases 2008;197 Suppl 2():S196-9.
2008: Galea Susan A; Sweet Ann; Beninger Paul; Steinberg Sharon P; Larussa Philip S; Gershon Anne A; Sharrar Robert G
The safety profile of varicella vaccine: a 10-year review.
The Journal of infectious diseases 2008;197 Suppl 2():S165-9.
2008: Gershon Anne A
Varicella-zoster virus infections.
Pediatrics in review / American Academy of Pediatrics 2008;29(1):5-10; quiz 11.
2007: Jean-Philippe Patrick; Freedman Abigail; Chang Mary Wu; Steinberg Sharon P; Gershon Anne A; LaRussa Philip S; Borkowsky William
Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction.
Pediatrics 2007;120(5):e1345-9.
2007: Breuer Judith; Quinlivan Mark; Al Bassam Mahmoud; Macdonald Susannah; Nichols Richard A; Steinberg Sharon P; Russa Philip La; Gershon Anne A
DNA sequence variability in Oka vaccine isolates.
The Journal of infectious diseases 2007;196(5):801-2; author reply 802-3.
2007: Hambleton S; Steinberg S P; Gershon M D; Gershon A A
Cholesterol dependence of varicella-zoster virion entry into target cells.
Journal of virology 2007;81(14):7548-58.
2007: Quinlivan Mark L; Gershon Anne A; Al Bassam Mahmoud M; Steinberg Sharon P; LaRussa Philip; Nichols Richard A; Breuer Judith
Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(1):208-12.
2006: Arvin Ann; Gershon Anne
Control of varicella: why is a two-dose schedule necessary?
The Pediatric infectious disease journal 2006;25(6):475-6.
2006: Quinlivan Mark A; Gershon Anne A; Nichols Richard A; La Russa Philip; Steinberg Sharon P; Breuer Judy
Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
The Journal of infectious diseases 2006;193(7):927-30.
2006: Stallings Christina L; Duigou Gregory J; Gershon Anne A; Gershon Michael D; Silverstein Saul J
The cellular localization pattern of Varicella-Zoster virus ORF29p is influenced by proteasome-mediated degradation.
Journal of virology 2006;80(3):1497-512.
2005: Hambleton Sophie; Gershon Anne A
The impact of varicella vaccination in the United States.
Seminars in pediatric infectious diseases 2005;16(1):38-43.
2005: Hambleton Sophie; Gershon Anne A
Preventing varicella-zoster disease.
Clinical microbiology reviews 2005;18(1):70-80.
2005: Gershon Anne
Contagiousness of varicella in vaccinated cases: a household contact study.
The Journal of pediatrics 2005;146(1):147.
2005: Quinlivan Mark; Gershon Anne A; Steinberg Sharon P; Breuer Judith
An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
Journal of medical virology 2005;75(1):174-80.
2004: Chen Jason J; Zhu Zhenglun; Gershon Anne A; Gershon Michael D
Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster.
Cell 2004;119(7):915-26.
2004: Hambleton S; Gershon M D; Gershon A A
The role of the trans-Golgi network in varicella zoster virus biology.
Cellular and molecular life sciences : CMLS 2004;61(24):3047-56.
2004: Gershon Anne A; Hambleton Sophie
Varicella vaccine for susceptible adults: do it today.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(11):1640-1.
2004: Quinlivan Mark L; Gershon Anne A; Steinberg Sharon P; Breuer Judith
Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.
The Journal of infectious diseases 2004;190(4):793-6.
2004: Vázquez Marietta; LaRussa Philip S; Gershon Anne A; Niccolai Linda M; Muehlenbein Catherine E; Steinberg Sharon P; Shapiro Eugene D
Effectiveness over time of varicella vaccine.
JAMA : the journal of the American Medical Association 2004;291(7):851-5.
2003: Chen Jason J; Gershon Anne A; Li Zhi Shan; Lungu Octavian; Gershon Michael D
Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus.
Journal of medical virology 2003;70 Suppl 1():S71-8.
2002: Gershon Anne A; Straus Stephen E
Samuel L. Katz: pioneer in development of and international advocate for vaccines.
Seminars in pediatric infectious diseases 2002;13(3):221-31.
2002: Ampofo Krow; Saiman Lisa; LaRussa Philip; Steinberg Sharon; Annunziato Paula; Gershon Anne
Persistence of immunity to live attenuated varicella vaccine in healthy adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(6):774-9.
2001: Gershon A A
Prevention and treatment of VZV infections in patients with HIV.
Herpes : the journal of the IHMF 2001;8(2):32-6.
2001: Saiman L; LaRussa P; Steinberg S P; Zhou J; Baron K; Whittier S; Della-Latta P; Gershon A A
Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2001;22(5):279-83.
2001: Gershon A A
Live-attenuated varicella vaccine.
Infectious disease clinics of North America 2001;15(1):65-81, viii.
2001: Vázquez M; LaRussa P S; Gershon A A; Steinberg S P; Freudigman K; Shapiro E D
The effectiveness of the varicella vaccine in clinical practice.
The New England journal of medicine 2001;344(13):955-60.
2001: Wang Z H; Gershon M D; Lungu O; Zhu Z; Mallory S; Arvin A M; Gershon A A
Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument.
Journal of virology 2001;75(1):323-40.
2001: Larussa P S; Gershon A A
Biologic and geographic differences between vaccine and clinical varicella-zoster virus isolates.
Archives of virology. Supplementum 2001;(17):41-8.
2001: Gershon A A
The current status of live attenuated varicella vaccine.
Archives of virology. Supplementum 2001;(17):1-6.
2000: LaRussa P; Steinberg S P; Shapiro E; Vazquez M; Gershon A A
Varicella vaccine revisited.
Nature medicine 2000;6(12):1299-300.
2000: Sharrar R G; LaRussa P; Galea S A; Steinberg S P; Sweet A R; Keatley R M; Wells M E; Stephenson W P; Gershon A A
The postmarketing safety profile of varicella vaccine.
Vaccine 2000;19(7-8):916-23.
2000: LaRussa P; Steinberg S P; Shapiro E; Vazquez M; Gershon A A
Viral strain identification in varicella vaccinees with disseminated rashes.
The Pediatric infectious disease journal 2000;19(11):1037-9.
2000: Wang Z H; Gershon M D; Lungu O; Zhu Z; Gershon A A
Trafficking of varicella-zoster virus glycoprotein gI: T(338)-dependent retention in the trans-Golgi network, secretion, and mannose 6-phosphate-inhibitable uptake of the ectodomain.
Journal of virology 2000;74(14):6600-13.
2000: Annunziato P W; Lungu O; Panagiotidis C; Zhang J H; Silvers D N; Gershon A A; Silverstein S J
Varicella-zoster virus proteins in skin lesions: implications for a novel role of ORF29p in chickenpox.
Journal of virology 2000;74(4):2005-10.
1999: Kohl S; Rapp J; La Russa P; Gershon A A; Steinberg S P
Natural varicella-zoster virus reactivation shortly after varicella immunization in a child.
The Pediatric infectious disease journal 1999;18(12):1112-3.
1999: Gershon M D; Gershon A A
Role of glycoproteins in varicella-zoster virus infection.
Contributions to microbiology 1999;3():43-60.
1998: Gershon A
Varicella: to vaccinate or not to vaccinate?
Archives of disease in childhood 1998;79(6):470-1.
1998: LaRussa P; Steinberg S; Arvin A; Dwyer D; Burgess M; Menegus M; Rekrut K; Yamanishi K; Gershon A
Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world.
The Journal of infectious diseases 1998;178 Suppl 1():S64-6.
1998: Annunziato P; LaRussa P; Lee P; Steinberg S; Lungu O; Gershon A A; Silverstein S
Evidence of latent varicella-zoster virus in rat dorsal root ganglia.
The Journal of infectious diseases 1998;178 Suppl 1():S48-51.
1998: Wang Z; Gershon M D; Lungu O; Panagiotidis C A; Zhu Z; Hao Y; Gershon A A
Intracellular transport of varicella-zoster glycoproteins.
The Journal of infectious diseases 1998;178 Suppl 1():S7-12.
1998: Derryck A; LaRussa P; Steinberg S; Capasso M; Pitt J; Gershon A A
Varicella and zoster in children with human immunodeficiency virus infection.
The Pediatric infectious disease journal 1998;17(10):931-3.
1998: Ussery X T; Annunziato P; Gershon A A; Reid B S; Lungu O; Langston C; Silverstein S; Lee K K; Baker C J
Congenital varicella-zoster virus infection and Barrett's esophagus.
The Journal of infectious diseases 1998;178(2):539-43.
1998: Lungu O; Panagiotidis C A; Annunziato P W; Gershon A A; Silverstein S J
Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(12):7080-5.
1998: Gershon A A; LaRussa P S
Varicella vaccine.
The Pediatric infectious disease journal 1998;17(3):248-9.
1997: Gershon A A; Mervish N; LaRussa P; Steinberg S; Lo S H; Hodes D; Fikrig S; Bonagura V; Bakshi S
Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection.
The Journal of infectious diseases 1997;176(6):1496-500.
1997: Gershon A A; Gardner P; Peter G; Nichols K; Orenstein W
Quality standards for immunization. Guidelines from the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(4):782-6.
1997: LaRussa P; Steinberg S; Meurice F; Gershon A
Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts.
The Journal of infectious diseases 1997;176(4):1072-5.
1997: Gershon A; Silverstein S
Live attenuated varicella vaccine for prevention of herpes zoster.
Biologicals : journal of the International Association of Biological Standardization 1997;25(2):227-30.
1997: Englund J A; Baker C J; Raskino C; McKinney R E; Petrie B; Fowler M G; Pearson D; Gershon A; McSherry G D; Abrams E J; Schliozberg J; Sullivan J L
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
The New England journal of medicine 1997;336(24):1704-12.
1997: Feder H M; LaRussa P; Steinberg S; Gershon A A
Clinical varicella following varicella vaccination: don't be fooled.
Pediatrics 1997;99(6):897-9.
1996: Annunziato P W; Gershon A
Herpes simplex virus infections.
Pediatrics in review / American Academy of Pediatrics 1996;17(12):415-23; quiz 424.
1996: Annunziato P; Lungu O; Gershon A; Silvers D N; LaRussa P; Silverstein S J
In situ hybridization detection of varicella zoster virus in paraffin-embedded skin biopsy samples.
Clinical and diagnostic virology 1996;7(2):69-76.
1996: LaRussa P; Steinberg S; Gershon A A
Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada.
The Journal of infectious diseases 1996;174 Suppl 3():S320-3.
1996: Zhu Z; Hao Y; Gershon M D; Ambron R T; Gershon A A
Targeting of glycoprotein I (gE) of varicella-zoster virus to the trans-Golgi network by an AYRV sequence and an acidic amino acid-rich patch in the cytosolic domain of the molecule.
Journal of virology 1996;70(10):6563-75.
1996: Gershon A A; LaRussa P; Steinberg S
The varicella vaccine. Clinical trials in immunocompromised individuals.
Infectious disease clinics of North America 1996;10(3):583-94.
1996: Gershon A A
Epidemiology and management of postherpetic neuralgia.
Seminars in dermatology 1996;15(2 Suppl 1):8-13.
1996: Gershon A A
More questions about varicella vaccination.
The Pediatric infectious disease journal 1996;15(6):560-1.
1996: Gershon A A; LaRussa P; Steinberg S; Mervish N; Lo S H; Meier P
The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox.
The Journal of infectious diseases 1996;173(2):450-3.
1995: Zhu Z; Gershon M D; Gabel C; Sherman D; Ambron R; Gershon A
Entry and egress of varicella-zoster virus: role of mannose 6-phosphate, heparan sulfate proteoglycan, and signal sequences in targeting virions and viral glycoproteins.
Neurology 1995;45(12 Suppl 8):S15-7.
1995: Zhu Z; Gershon M D; Hao Y; Ambron R T; Gabel C A; Gershon A A
Envelopment of varicella-zoster virus: targeting of viral glycoproteins to the trans-Golgi network.
Journal of virology 1995;69(12):7951-9.
1995: Lungu O; Annunziato P W; Gershon A; Staugaitis S M; Josefson D; LaRussa P; Silverstein S J
Reactivated and latent varicella-zoster virus in human dorsal root ganglia.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(24):10980-4.
1995: Gershon A A
Development of live attenuated varicella vaccine.
Proceedings of the Association of American Physicians 1995;107(3):365-8.
1995: Gershon A A
Varicella vaccine: its past, present and future.
The Pediatric infectious disease journal 1995;14(9):742-4.
1995: Gershon A A
Present and future challenges of immunizations on the health of our patients.
The Pediatric infectious disease journal 1995;14(5):445-9.
1995: Zhu Z; Gershon M D; Ambron R; Gabel C; Gershon A A
Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(8):3546-50.
1995: Hollinger F B; Eickhoff T; Gershon A; Jong E C; Koff R S
Discussion: who should receive hepatitis A vaccine? A strategy for controlling hepatitis A in the United States.
The Journal of infectious diseases 1995;171 Suppl 1():S73-7.
1995: Gershon A A
Varicella-zoster virus: prospects for control.
Advances in pediatric infectious diseases 1995;10():93-124.
1994: Gershon A A; Sherman D L; Zhu Z; Gabel C A; Ambron R T; Gershon M D
Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network.
Journal of virology 1994;68(10):6372-90.
1994: Gershon A A; Larussa P; Steinberg S
Detection of antibodies to varicella-zoster virus using a latex agglutination assay.
Clinical and diagnostic virology 1994;2(4-5):271-7.
1994: Hughes P; LaRussa P; Pearce J M; Lepow M; Steinberg S; Gershon A
Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction.
The Journal of pediatrics 1994;124(6):932-5.
1993: Gershon A A
Immunizations for pediatric transplant patients.
Kidney international. Supplement 1993;43():S87-90.
1992: Gershon A A; LaRussa P; Hardy I; Steinberg S; Silverstein S
Varicella vaccine: the American experience.
The Journal of infectious diseases 1992;166 Suppl 1():S63-8.
1992: Gershon A A
Varicella vaccine: still at the crossroads.
Pediatrics 1992;90(1 Pt 2):144-8.
1992: LaRussa P; Lungu O; Hardy I; Gershon A; Steinberg S P; Silverstein S
Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates.
Journal of virology 1992;66(2):1016-20.
1991: Gershon A A
Human immune responses to live attenuated varicella vaccine.
Reviews of infectious diseases 1991;13 Suppl 11():S957-9.
1991: Hardy I; Gershon A A; Steinberg S P; LaRussa P
The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
The New England journal of medicine 1991;325(22):1545-50.
1991: Steinberg S P; Gershon A A
Measurement of antibodies to varicella-zoster virus by using a latex agglutination test.
Journal of clinical microbiology 1991;29(7):1527-9.
1990: LaRussa P S; Gershon A A; Steinberg S P; Chartrand S A
Antibodies to varicella-zoster virus glycoproteins I, II, and III in leukemic and healthy children.
The Journal of infectious diseases 1990;162(3):627-33.
1990: Gershon A A
Immunization practices in children.
Hospital practice (Office ed.) 1990;25(9):91-4, 97-103, 107.
1990: Gershon A A
Viral vaccines of the future.
Pediatric clinics of North America 1990;37(3):689-707.
1990: Gershon A A; Steinberg S P
Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
The Journal of infectious diseases 1990;161(4):661-6.
1990: Hardy I R; Gershon A A
Prospects for use of a varicella vaccine in adults.
Infectious disease clinics of North America 1990;4(1):159-73.
1990: Tsolia M; Gershon A A; Steinberg S P; Gelb L
Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
The Journal of pediatrics 1990;116(2):184-9.
1989: Gabel C A; Dubey L; Steinberg S P; Sherman D; Gershon M D; Gershon A A
Varicella-zoster virus glycoprotein oligosaccharides are phosphorylated during posttranslational maturation.
Journal of virology 1989;63(10):4264-76.
1989: Hammerschlag M R; Gershon A A; Steinberg S P; Clarke L; Gelb L D
Herpes zoster in an adult recipient of live attenuated varicella vaccine.
The Journal of infectious diseases 1989;160(3):535-7.
1989: Gershon A A; Steinberg S P
Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
The New England journal of medicine 1989;320(14):892-7.
1988: Gershon A A; Steinberg S P; LaRussa P; Ferrara A; Hammerschlag M; Gelb L
Immunization of healthy adults with live attenuated varicella vaccine.
The Journal of infectious diseases 1988;158(1):132-7.
1988: Dubey L; Steinberg S P; LaRussa P; Oh P; Gershon A A
Western blot analysis of antibody to varicella-zoster virus.
The Journal of infectious diseases 1988;157(5):882-8.
1987: Gelb L D; Dohner D E; Gershon A A; Steinberg S P; Waner J L; Takahashi M; Dennehy P H; Brown A E
Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults.
The Journal of infectious diseases 1987;155(4):633-40.
1986: Gershon A A; Steinberg S P; Gelb L
Live attenuated varicella vaccine use in immunocompromised children and adults.
Pediatrics 1986;78(4 Pt 2):757-62.
1985: Williams D L; Gershon A A; Gelb L D; Spraker M K; Steinberg S; Ragab A H
Herpes zoster following varicella vaccine in a child with acute lymphocytic leukemia.
The Journal of pediatrics 1985;106(2):259-61.
1985: Gershon A A; Steinberg S; Gelb L; Galasso G; Borkowsky W; LaRussa P; Ferrara A
A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.
Postgraduate medical journal 1985;61 Suppl 4():73-8.
1984: Gershon A A; Steinberg S; Galasso G; Borkowsky W; Larussa P; Ferrara A; Gelb L
Live attenuated varicella vaccine in children with leukemia in remission.
Biken journal 1984;27(2-3):77-81.
1984: Gershon A A; Steinberg S P; Gelb L; Galasso G; Borkowsky W; LaRussa P; Farrara A
Live attenuated varicella vaccine. Efficacy for children with leukemia in remission.
JAMA : the journal of the American Medical Association 1984;252(3):355-62.
1984: Gershon A A; Steinberg S P; Gelb L
Clinical reinfection with varicella-zoster virus.
The Journal of infectious diseases 1984;149(2):137-42.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Anne Gershon

Research Profile (preview)

Living Beings

Chemicals & Drugs

Disorders

Procedures

Geographic Areas

Physiology

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Anne Gershon (preview)

All Publications